Sort
15,842 grants matching “pancreatic cancer”
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
$592,815Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)
$592,291Ajit Harishkumar Goenka · Mayo Clinic Rochester · R01 · FY2023 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$592,164Shan Zha · Columbia University Health Sciences · R01 · FY2025 · CA
Molecular Epidemiology of Pancreatic Cancer
$592,038University Of California San Francisco · R01 · FY2005 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$592,013Alec Kimmelman · New York University School Of Medicine · R35 · FY2018 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$591,868Farrokh Dehdashti · Washington University · R01 · FY2022 · CA
Protein Structure, Stability, and Amyloid Formation
$591,716Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$591,430Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Tumor subtypes and therapy response in pancreatic cancer
$591,406Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
$591,242Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Image-Guided System for Cancer Intervention
$591,060Kirby Gannett Vosburgh · Ascension Technology Corporation · R42 · FY2008 · CA
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
$591,023Joo H Hwang · Stanford University · R01 · FY2020 · CA
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
$590,577Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2017 · CA
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
$590,577Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2020 · CA
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
$590,572Julie R Palmer · Boston University Medical Campus · U01 · FY2017 · CA
In Vivo Base Editing for Precision Oncology Models
$590,350Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$590,123Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$590,100Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2023 · CA
ProAgio in Pancreatic Cancer
$590,094Bassel El-Rayes · University Of Alabama At Birmingham · R01 · FY2024 · CA
Somatostatin receptors in the diagnosis and treatment of thyroid cancer
$590,067Joanna Klubo-Gwiezdzinska · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Optimization of an active mutant KRAS peptide vaccine in colorectal cancer
$589,838Nilofer S. Azad · Johns Hopkins University · R01 · FY2025 · CA
Development of sEphB4-HSA as Novel Therapeutic in Cancer
$589,768Valery G Krasnoperov · Vasgene Therapeutics, Inc · R44 · FY2014 · CA
Predictive Cancer Diagnostics and Therapy Response
$589,368Anna Moore · Massachusetts General Hospital · R01 · FY2014 · CA
IDBR: Collaborative Research: Real time secretion: single cell analyzer
$589,208James A Glazier · Indiana University · · FY2012 · BIO
Multiplexed imaging of biliary intra-epithelial neoplasia
$589,117Eric J Seibel · University Of Washington · R01 · FY2016 · CA